High Triglycerides News and Research

RSS
PK molecule could be a target for vascular complications linked to type 1 diabetes

PK molecule could be a target for vascular complications linked to type 1 diabetes

Study: Mother Nature may help lower cholesterol levels in pregnant women

Study: Mother Nature may help lower cholesterol levels in pregnant women

Doctors in Mexico show benefits of healthy diet, exercise in heart failure patients

Doctors in Mexico show benefits of healthy diet, exercise in heart failure patients

Severely obese children face higher risk of developing heart disease, diabetes

Severely obese children face higher risk of developing heart disease, diabetes

Reducing SSB intake among children and adolescents associated with greater increase in HDL-C

Reducing SSB intake among children and adolescents associated with greater increase in HDL-C

New NIH grants support research that combines DNA sequence information and electronic medical records

New NIH grants support research that combines DNA sequence information and electronic medical records

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Novel findings may hold promise for children, adults with mitochondrial disorders

Novel findings may hold promise for children, adults with mitochondrial disorders

Study: Omega-3 fatty acids appear to protect heart function among heart attack survivors

Study: Omega-3 fatty acids appear to protect heart function among heart attack survivors

Isis Pharmaceuticals announces positive results from Phase 1 study of ISIS-PKK Rx for HAE treatment

Isis Pharmaceuticals announces positive results from Phase 1 study of ISIS-PKK Rx for HAE treatment

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

PE/GHTN linked to higher frequency of cardiovascular and metabolic abnormalities

PE/GHTN linked to higher frequency of cardiovascular and metabolic abnormalities

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

Women’s risk factors for heart disease

Women’s risk factors for heart disease

Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients

Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients

Researchers pinpoint rare gene mutations that increase risk of heart attack early in life

Researchers pinpoint rare gene mutations that increase risk of heart attack early in life

Isis Pharmaceuticals CEO honored with SCRIP Lifetime Achievement Award

Isis Pharmaceuticals CEO honored with SCRIP Lifetime Achievement Award

Early brain imaging studies may help prevent vascular diseases

Early brain imaging studies may help prevent vascular diseases